Amid the uncertainty of COVID-19 in 2020, consumer health companies scaled back on mergers and acquisitions, instead focusing on portfolio rationalisation and cost cutting. In 2021, the industry is expecting a strong bounce back to historic rates of M&A activity, especially in categories with many emerging brands, like vitamins and dietary supplements. This briefing evaluates the industry’s expected buyers in 2021 and examines the products that are most likely to change hands.
From Portfolio Rationalisation to A Flurry of Spending: M&A in Consumer Health in 2021 and Beyond global briefing examines the size, growth trends and potential opportunities in the Consumer Health market. The strategic analyses include assessing the impacts of changing regulations, research breakthroughs and public health concerns on both the market and leading companies. Consumer attitudes towards the products and their personal healthcare needs are also explored.
Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report? * Get a detailed picture of the Consumer Health market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Our reports have been used by over 10K customers, including:
Forecasts by Distribution Channel (Pharmacies/Drugstores, Supermarkets/Hypermarkets, Convenience Stores, Online Drugstores, Health Food Stores), by Category (Cough, Cold and Flu Drugs, Analgesics, Dermatological, Vitamins and Minerals, Weight Loss/Diet Products, Gastrointestinal Drugs, Allergy, Other), by Dosage Form (Tablets, Hard...
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this U.S. OTC Drugs Market Report
The U.S. OTC drugs market by revenue is expected to grow at a CAGR of 4.01% during the period 2021–2026.
U.S. OTC DRUGS MARKET: KEY HIGHLIGHTS
• In 2020, online pharmacies and hospital pharmacies segments...
104 pages •
By Future Market Insight Global & Consulting Pvt Ltd
• Jun 2021
A recent market study published on the digital ovulation test kit market offers the U.S. industry analysis for 2016-2021 & an opportunity assessment for 2021-2031. The report consists of a comprehensive assessment of the most important market dynamics. On conducting thorough research on the historical as well as current growth parameters of...
65 pages •
By Euromonitor International
• Mar 2021
This report analyses the market for consumer health in Cambodia. For the purposes of the study, the market has been defined as follows:
Consumer Health in Cambodia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2016-2020, allowing you to identify...
OTC Medications in Japan provides you with annual year-end market size data, most recently updated in 2021. This market covers analgesics, cough/cold/flu, gastro-intestinal, dermatological remedies and vitamins and minerals. It excludes all other OTC products and those which require prescriptions but includes pharmacy...
The US dermatology OTC medications market was valued at US$ 952.97 million in 2020 and is projected to reach US$ 1,124.56 million by 2028; it is expected to grow at a CAGR of 2.1% from 2021 to 2028. Rising prevalence of skin abnormalities and increasing availability of dermatology medication over the counter (OTC) are the key factors fueling...
52 pages •
By Euromonitor International
• Aug 2021
The report will explore the key themes transforming consumer behaviour in Asia Pacific in the world beyond the pandemic, namely Digital Living, Rethink Wellness, Sustainable Living, Make My Life Easier and Search for Experiences, and the strategies businesses should invest in to stay relevant, to build on existing brand equity and to create...
The US pet market is anticipated to reach US$127.87 billion in 2025, experiencing growth at a CAGR of 3.50% during the period spanning from 2021 to 2025. The market growth was driven by various factors such as rise in millennial population, growing adoption of e-commerce in pet care products and increasing share of single-person households....
Healthy start: A recovering economy is expected to boost industry revenue growth Abstract Pharmacies & Drug Stores in the US Over the five years to 2019, the Pharmacies and Druge Stores industry exhibited growth despite some adverse side effects from the regulatory environment and growing external competition....
Big changes: Increased external competition from clinics and hospitals has hurt industry Abstract Weight Loss Service Franchises This industry includes franchised establishments that provide nonmedical services to assist clients with losing weight or maintaining a desired weight level. Reports in IBISWorld’s...
Research And Development
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.